Drug Price Increases After Passage Of Medicare Benefit Undermine Law's Intent - AARP
This article was originally published in The Pink Sheet Daily
Executive Summary
Pricing data from AARP's latest "Rx Watchdog Report" reveals a "big jump" in drug prices after the Medicare drug benefit was signed into law in 2003. Drug prices rose by an average of 3.4% during the first quarter of 2004, according to the report.